Gabapentin Capsule
Product Images NDC 85509-2180

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 85509-2180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (2180 3)

Label (2180 3)
This text provides information about gabapentin capsules containing 300 mg of gabapentin, USP. It includes details on dosage, storage instructions, dispensing guidelines, and manufacturer information. The QR code on the package insert can be scanned for full prescribing information, and patients should be given the Medication Guide. The capsules come in a pack of 30 and are for prescription use only. The medication should be stored at 20° to 25°C (68° to 77°F) and kept out of reach of children.*
FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This text seems to describe a clinical trial evaluating the efficacy of different doses of Gabapentin in managing pain. The study compares pain scores over a 4-week period in participants receiving a placebo and two different doses of Gabapentin - 1800 mg/day and 2400 mg/day. The results are displayed graphically with a baseline and subsequent pain scores at different weeks.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
This description provides information on the proportion of responders (patients showing at least a 50% reduction in pain score) in controlled post-herpetic neuralgia (PHN) studies. The data comparison includes percentages from Study 1 and Study 2 for different dosages of PBO (placebo) and GBP (gabapentin). This information can be utilized to evaluate the efficacy of GBP in treating pain associated with PHN.*
FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)
This appears to be a table showing a daily dose in milligrams over a period. The data seems to vary from 600 mg to 1600 mg.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.